Title | Prevalence of EBV in household contacts of patients with nasopharyngeal carcinoma | |
Author | Stavros D. Kottaridis, Irene Goula and George StathopoulosDepartment of Virology, Hellenic Anticancer Institute, Papanicolaou Research Center of Oncology, Athens | |
Citation | Kottaridis, S.D., Goula, I., Stathopoulos, G.: Prevalence of EBV in household contacts of patients with nasopharyngeal carcinoma, Epitheorese Klin. Farmakol. Farmakokinet. 1(1): 55-60 (1987) | |
Publication Date | 1987-07 | |
Full Text Language | English | |
Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)pharmakonpress[at]pharmakonpress[.]gr | |
Keywords | Epstein-Barr virus, household, mononucleosis, Burkitt’s lymphoma, nasopharyngeal carcinoma, antigens, family, patients, antibodies, EBV, transmission, viral infection. | |
Other Terms | review article | |
Summary | Epstein-Barr Virus is the causative agent of infectious mononucleosis and it has been associated with Burkitt’s lymphoma, nasopharyngeal carcinoma and other nonspecific manifestations. The contagiousness of this virus and the impact of the infection among individuals is of particular concern and all, up to date, reports are refutatory. We studied the presence of antibodies to EBV related antigens in family members of patients with nasopharyngeal carcinoma. This study indicated that interpersonal transmission of virus does not occur readily within household contacts and that other factors may be implicated in the transmission of viral infection. | |
References | 1. Sumaya, C.V., Henle, W., Henle, G., et al.: Seroepidemiologic study of Epstein-Barr virus in a rural, community. J. Infect. Dis. 131: 403 (1975)2. Joncas, J., Boucher, J., Granger-Julien, M. et al.: Epstein-Barr virus infection in the neonatal period and in childhood. Can. Med. Assoc. J. 110: 33 (1974)
3. Miller, G., Niederman, J.C., Andrews, LL: Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N. Engl. J. Med. 228: 229 (1973) 4. Tobi, M., Morag, A., Ravid, Z. et al.: Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1: 61 (1982) 5. Jones, J.F., Ray, C.G., Minnich, L.L. et al.: Evidence for active Epstein-Barr virus infections in patients with persistent, unexplained illness. Elevated anti-early antigen antibodies. Ann. Intern. Med. 102: 1 ‘ (1985) 6. Kottaridis, S.D., Dafnou, M., Besbeas, S. et al.: Antibodies to EBV-in nasopharyngeal carcinoma and other neoplastic conditions. J. Natl. Cancer Inst. 59: 89 (1977) 7. Klein, G., Giovanella, B.C., Lindahl, T. et al.: Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. USA 71: 4737 (1974) 8. Joncas, J.H.: Clinical significance of the EB herpesvirus infection in man. Prog. Med. Virol. 14: 200 (1972) 9. Kottaridis, S., Gouls, I., Deligiorgis, D.: Epstein-Barr virus serology in Greek children. Hellenic Oncology 19: 200 (1983) 10. Henle, G., Henle, W., Ho, H.C. et al.: Antibodies to Ep- stein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasma and control groups. N. Engl. Cancer Inst. 44: 225 (1970) 11. Niederman, J.C., Miller, G., Pearson, H.A. et al.: Infectious mononucleosis. Epstein-Barr virus shedding in saliva and the oropharynx. N. Engl. J. Med. 294: 1355 (1976) 12. Gerber, P., Nonoyama, M., Lucas, S. et al.: Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 2: 988 (1 972) 13. Reedman, B.M., Klein, G.: Cellular localization of an Epstein-Barr virus (EBV) – associated complement – fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11: 494 (1973) 14. Nevo, S., Meyer, W„ Altman, M.: Carcinoma of nasopharynx in twins. Cancer 28: 807 (1971) 15. Simons, M.J., Wee, G.B., Day, N.E. et al.: Immunogenetic aspects of nasopharyngeal carcinoma. I. Differences in HLA antigen profiles between patients and control groups. Int. J. Cancer 13: 122 (1974) 16. Porter, D.D., Wimberly, I., Benyesh-Melnick, M.: Prevalence of antibodies to EB virus and other herpesviruses. J.A.M.A. 208: 1675 (1969) 17. Ho, H.C.: Current knowledge of the epidemiology of nasopharyngeal carcinoma – a review. In: Oncogenesis and Herpesviruses (Biggs, P.M., de-The, G., Payne, L.N., eds), p. 357, Lyon, IARC, 1972 18. Williams, E.H., de-Th6, G.: Familial aggregation in nasopharyngeal carcinoma. Lancet 2: 295 (1974) 19. Lanier, A.P., Bender, T.R., Tschopp, C. et al.: Nasopharyngeal carcinoma in a Alaskan Eskimo family. J. Natl. Cancer Inst. 62: 1121 (1979). |
|
Relative Papers |
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 1987 – ANNUAL SUBSCRIPTION 1987 | |
Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)pharmakonpress[at]pharmakonpress[.]gr |
Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)pharmakonpress[at]pharmakonpress[.]gr |